A randomized blinded trial of combination therapy with cyclophosphamide in patients with active multiple sclerosis on interferon beta
Duane R. Smith(Wellcome Trust), H L Weiner(Brigham and Women's Hospital), Xing‐Chang Wei(Brigham and Women's Hospital), Steven J. Greenberg, L. Stone(Cleveland Clinic), Jeffrey A. Cohen(Dartmouth Health), David Stuart(Peachtree Orthopaedic Clinic), Bianca Weinstock‐Guttman(Jacobs Institute), Michael J. Olek(Touro University Nevada), W. H. Stuart(University of Maryland, Baltimore), C. Gutmann(Brigham and Women's Hospital), Rohit Bakshi(Brigham and Women's Hospital), John Orav(Brigham and Women's Hospital)
Cited by 82
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials
|BMJ|2009|1.3k
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624